Lexeo Therapeutics, Inc. LXEO
Set alert
3.08 USD +0.02 +0.49%
As of Nov 3, 1:04 PM ET
3.01 Day range 3.30
2.63 52-week range 10.63
- YTD
- -69.03%
- 1 year
- -65.98%
- Open
- 3.10
- Prev close
- 3.06
- Mkt cap
- 252.42M
- Vol
- 494.98K
- Avg vol
- 1.31M
- EPS
- -1.02
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 3.01
- High
- 3.30
- Forward P/E
- -2.24
- Beta
- 0.00
- Short ratio
- 6.55
- Inst. own
- 91.48%
- Dividend
- 0.00
- Ex-div date
- Earnings
- May 9, 2024
- 50-d avg
- 7.92
- 200-d avg
- 11.86
- 1y target
- 22.29
Analyst view
Price target (mean) 22.29 +624.7% upside
Now 3.08
- Target (low)
- 16.00
- Target (mean)
- 22.29
- Target (high)
- 28.00
Ratings (0m) 7 7 buy · 0 hold · 0 sell
- Strong buy3
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 7
- 1 month ago 6
- 2 months ago 7
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.77664 | -0.90 – -0.60986 | 0.00 | 0.0% | 0 | 0.0% | 6 |
| Next quarter | -0.795 | -0.93 – -0.53 | -0.77 | -3.3% | 0 | 0.0% | 4 |
| Current year | -2.75 | -3.01 – -2.55 | -12.30 | +77.6% | 0 | 0.0% | 6 |
| Next year | -3.01 | -3.84 – -1.79 | -2.75 | -9.4% | 750.00K | 0.0% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 14, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Nov 13, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Nov 13, 2024 | Leerink Partners | Maintained | Outperform | Outperform |
| Oct 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Oct 30, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Oct 25, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Aug 14, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Aug 13, 2024 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 13, 2024 | RBC Capital | Reiterated | Outperform | Outperform |
| Jul 16, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Jul 15, 2024 | Chardan Capital | Maintained | Buy | Buy |
| Jun 13, 2024 | Baird | Initiated | — | Outperform |
| Jun 6, 2024 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 12, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Nov 28, 2023 | Chardan Capital | Initiated | — | Buy |
| Nov 28, 2023 | Leerink Partners | Initiated | — | Outperform |
| Nov 28, 2023 | RBC Capital | Initiated | — | Outperform |
| Nov 28, 2023 | Stifel | Initiated | — | Buy |
| Nov 28, 2023 | JP Morgan | Initiated | — | Overweight |